Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal administration. It is indicated for the management of allergic rhinitis and nasal polyps, where it reduces mucosal inflammation and edema in the upper airway.

GNH USA supplies Nasonex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to stringent quality assurance protocols and offers comprehensive logistics support to ensure product integrity across global supply chains.

Nasonex (mometasone furoate) is a nasal corticosteroid used to treat inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons. - Nasal polyps: decreases polyp size and improves nasal airflow.

Nasonex may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning - Headache - Epistaxis (nosebleed) - Throat irritation

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Adrenal suppression with long‑term high‑dose use

Before using Nasonex, consider the following precautions: - Pregnancy: consult a healthcare provider; safety not established. - Breastfeeding: unknown; weigh benefits against potential risks. - Use in children: approved for specific age groups; follow prescriber guidance. - Avoid concurrent intranasal steroids to prevent excess systemic exposure. - Monitor for signs of infection or unusual bleeding. - Store at room temperature: keep in the original container, protect from moisture and heat.

Nasonex may interact with other medications.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise intranasal mometasone concentrations.

Moderate Interactions (Monitor Closely): - Antihistamines: possible increased nasal irritation. - Nasal decongestants (oxymetazoline): may enhance local dryness. - Live vaccines: potential reduced immune response when systemic absorption occurs.